{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:27:08Z","timestamp":1790486828717,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Blood\u2013brain barrier (BBB) dysfunction is supposed to be an early event in the development of Alzheimer\u2019s disease (AD). This study aimed to investigate the relationship between BBB alterations and AD progression in terms of amyloid-\u03b2 peptide (A\u03b2) accumulation in the brains of humanized amyloid precursor protein knock-in (APP-KI) mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Brain A\u03b2 accumulation was examined using immunohistochemical analysis. Alterations in differentially expressed proteins were determined using sequential window acquisition of all theoretical fragment ion mass spectroscopy (SWATH-MS)-based quantitative proteomics, and Metascape, STRING, Gene Ontology, and KEGG were used for network analyses of altered biological pathways and processes. Statistical significance was determined using the unpaired two-tailed Student\u2019s <jats:italic>t<\/jats:italic>-test and Welch\u2019s <jats:italic>t<\/jats:italic>-test for two groups and one-way analysis of variance followed by Tukey\u2019s test for more than two groups. Correlations between two groups were determined using Pearson\u2019s correlation analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Brain A\u03b2 accumulation in APP-KI mice was detectable at 2\u00a0months, increased significantly at 5\u00a0months, and remained elevated at 12\u00a0months of age. The levels of differentially expressed proteins in isolated brain capillaries were higher in younger mice, whereas those in the brain were higher in older mice. Network analyses indicated changes in basement membrane-associated and ribosomal proteins in the brain capillaries. There were no significant changes in key proteins involved in drug or A\u03b2 transport at the BBB. In contrast, solute carrier transporter levels in astrocytes, microglia, and neurons were altered in the brain of older mice. Moreover, the levels of the lipid transporters Apoe and Apoj were upregulated in both the brain and isolated brain capillaries after A\u03b2 accumulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results suggest that changes in the brain occurred after advanced A\u03b2 accumulation, whereas initial A\u03b2 accumulation was sufficient to cause alterations in the BBB. These findings may help elucidate the role of BBB alterations in AD progression and predict the distribution of drugs across the BBB in the brain of patients with AD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12987-023-00466-9","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T23:03:00Z","timestamp":1694646180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Proteomic alterations in the brain and blood\u2013brain barrier during brain A\u03b2 accumulation in an APP knock-in mouse model of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Shingo","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiryo","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi","family":"Saido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumio","family":"Ohtsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"issue":"6","key":"466_CR1","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","volume":"80","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Holtzman DM. Biomarker modeling of Alzheimer\u2019s disease. Neuron. 2013;80(6):1347\u201358.","journal-title":"Neuron"},{"issue":"10","key":"466_CR2","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1177\/0271678X17722436","volume":"37","author":"MS Thomsen","year":"2017","unstructured":"Thomsen MS, Routhe LJ, Moos T. The vascular basement membrane in the healthy and pathological brain. J Cereb Blood Flow Metab. 2017;37(10):3300\u201317.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"466_CR3","doi-asserted-by":"crossref","first-page":"e36893","DOI":"10.1371\/journal.pone.0036893","volume":"7","author":"JM Hunter","year":"2012","unstructured":"Hunter JM, Kwan J, Malek-Ahmadi M, Maarouf CL, Kokjohn TA, Belden C, Sabbagh MN, Beach TG, Roher AE. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer\u2019s disease. PLoS ONE. 2012;7(5):e36893.","journal-title":"PLoS ONE"},{"key":"466_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1997.tb48467.x","author":"C Zarow","year":"1997","unstructured":"Zarow C, Barron E, Chui HC, Perlmutter LS. Vascular basement membrane pathology and Alzheimer\u2019s disease. Ann N Y Acad Sci. 1997;826:147\u201360.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"466_CR5","first-page":"671","volume":"45","author":"T Kimura","year":"1991","unstructured":"Kimura T, Hashimura T, Miyakawa T. Observations of microvessels in the brain with Alzheimer\u2019s disease by the scanning electron microscopy. Jpn J Psychiatry Neurol. 1991;45(3):671\u20136.","journal-title":"Jpn J Psychiatry Neurol"},{"issue":"10","key":"466_CR6","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jalz.2017.02.007","volume":"13","author":"RB Nielsen","year":"2017","unstructured":"Nielsen RB, Egefjord L, Angleys H, Mouridsen K, Gejl M, M\u00f8ller A, Brock B, Br\u00e6ndgaard H, Gottrup H, Rungby J, Eskildsen SF, \u00d8stergaard L. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer\u2019s disease. Alzheimers Dement. 2017;13(10):1143\u201353.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"466_CR7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M, Zlokovic BV. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85(2):296\u2013302.","journal-title":"Neuron"},{"issue":"2","key":"466_CR8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Chui HC, Law M, Toga AW, Zlokovic BV. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25(2):270\u20136.","journal-title":"Nat Med"},{"issue":"12","key":"466_CR9","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jalz.2019.07.012","volume":"15","author":"A Montagne","year":"2019","unstructured":"Montagne A, Huuskonen MT, Rajagopal G, Sweeney MD, Nation DA, Sepehrband F, D\u2019Orazio LM, Harrington MG, Chui HC, Law M, Toga AW, Zlokovic BV. Undetectable gadolinium brain retention in individuals with an age-dependent blood-brain barrier breakdown in the hippocampus and mild cognitive impairment. Alzheimers Dement. 2019;15(12):1568\u201375.","journal-title":"Alzheimers Dement"},{"issue":"7806","key":"466_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D\u2019Orazio LM, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Reiman EM, Caselli RJ, Chui HC, Tcw J, Chen Y, Pa J, Conti PS, Law M, Toga AW, Zlokovic BV. Apoe4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71\u20136.","journal-title":"Nature"},{"issue":"7","key":"466_CR11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2006.05.016","volume":"28","author":"BD Zipser","year":"2007","unstructured":"Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, Vitek MP, Hovanesian V, Stopa EG. Microvascular injury and blood-brain barrier leakage in Alzheimer\u2019s disease. Neurobiol Aging. 2007;28(7):977\u201386.","journal-title":"Neurobiol Aging"},{"key":"466_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11934","author":"Y Iturria-Medina","year":"2016","unstructured":"Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Perez JM, Evans AC. Alzheimer\u2019s disease neuroimaging I. Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun. 2016;7:11934.","journal-title":"Nat Commun"},{"issue":"1","key":"466_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2045-8118-9-23","volume":"9","author":"AC Luissint","year":"2012","unstructured":"Luissint AC, Artus C, Glacial F, Ganeshamoorthy K, Couraud PO. Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS. 2012;9(1):23.","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"466_CR14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/brain\/awz011","volume":"142","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Shinohara M, Shinohara M, Yamazaki A, Murray ME, Liesinger AM, Heckman MG, Lesser ER, Parisi JE, Petersen RC, Dickson DW, Kanekiyo T, Bu G. Selective loss of cortical endothelial tight junction proteins during Alzheimer\u2019s disease progression. Brain. 2019;142(4):1077\u201392.","journal-title":"Brain"},{"issue":"1","key":"466_CR15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","volume":"2","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W, Potschka H. Blood-brain barrier active efflux transporters: Atp-binding cassette gene family. NeuroRx. 2005;2(1):86\u201398.","journal-title":"NeuroRx"},{"issue":"4","key":"466_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.0b013e31827f0889","volume":"80","author":"R Ossenkoppele","year":"2013","unstructured":"Ossenkoppele R, van der Flier WM, Zwan MD, Adriaanse SF, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van Berckel BN. Differential effect of apoe genotype on amyloid load and glucose metabolism in ad dementia. Neurology. 2013;80(4):359\u201365.","journal-title":"Neurology"},{"issue":"3","key":"466_CR17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/2013.jamaneurol.286","volume":"70","author":"HD Protas","year":"2013","unstructured":"Protas HD, Chen K, Langbaum JB, Fleisher AS, Alexander GE, Lee W, Bandy D, de Leon MJ, Mosconi L, Buckley S, Truran-Sacrey D, Schuff N, Weiner MW, Caselli RJ, Reiman EM. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for alzheimer disease. JAMA Neurol. 2013;70(3):320\u20135.","journal-title":"JAMA Neurol"},{"issue":"6","key":"466_CR18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11307-012-0556-0","volume":"14","author":"DM van Assema","year":"2012","unstructured":"van Assema DM, Lubberink M, Boellaard R, Schuit RC, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN. P-glycoprotein function at the blood-brain barrier: effects of age and gender. Mol Imaging Biol. 2012;14(6):771\u20136.","journal-title":"Mol Imaging Biol"},{"issue":"11","key":"466_CR19","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","volume":"115","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, Paul SM, Zlokovic BV, Piwnica-Worms D, Holtzman DM. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Investig. 2005;115(11):3285\u201390.","journal-title":"J Clin Investig"},{"issue":"6","key":"466_CR20","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1523\/JNEUROSCI.0350-15.2016","volume":"36","author":"AM Hartz","year":"2016","unstructured":"Hartz AM, Zhong Y, Wolf A, LeVine H 3rd, Miller DS, Bauer B. A\u03b240 reduces p-glycoprotein at the blood-brain barrier through the ubiquitin-proteasome pathway. J Neurosci. 2016;36(6):1930\u201341.","journal-title":"J Neurosci"},{"issue":"6","key":"466_CR21","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-008-9532-4","volume":"25","author":"J Kamiie","year":"2008","unstructured":"Kamiie J, Ohtsuki S, Iwase R, Ohmine K, Katsukura Y, Yanai K, Sekine Y, Uchida Y, Ito S, Terasaki T. Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous lc\/ms\/ms method combined with novel in-silico peptide selection criteria. Pharm Res. 2008;25(6):1469\u201383.","journal-title":"Pharm Res"},{"issue":"5","key":"466_CR22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N, Saido TC. Single app knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci. 2014;17(5):661\u20133.","journal-title":"Nat Neurosci"},{"issue":"10","key":"466_CR23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11095-019-2674-8","volume":"36","author":"S Ogata","year":"2019","unstructured":"Ogata S, Ito S, Masuda T, Ohtsuki S. Changes of blood-brain barrier and brain parenchymal protein expression levels of mice under different insulin-resistance conditions induced by high-fat diet. Pharm Res. 2019;36(10):141.","journal-title":"Pharm Res"},{"issue":"1","key":"466_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-8118-10-21","volume":"10","author":"Y Uchida","year":"2013","unstructured":"Uchida Y, Tachikawa M, Obuchi W, Hoshi Y, Tomioka Y, Ohtsuki S, Terasaki T. A study protocol for quantitative targeted absolute proteomics (qtap) by lc-ms\/ms: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddy, fvb, and c57bl\/6j mice. Fluids Barriers CNS. 2013;10(1):21.","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"466_CR25","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/0271678X20941449","volume":"41","author":"S Ogata","year":"2021","unstructured":"Ogata S, Ito S, Masuda T, Ohtsuki S. Efficient isolation of brain capillary from a single frozen mouse brain for protein expression analysis. J Cereb Blood Flow Metab. 2021;41(5):1026\u201338.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"466_CR26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1021\/pr700658q","volume":"7","author":"T Masuda","year":"2008","unstructured":"Masuda T, Tomita M, Ishihama Y. Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. J Proteome Res. 2008;7(2):731\u201340.","journal-title":"J Proteome Res"},{"issue":"1","key":"466_CR27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev V, Messner CB, Vernardis SI, Lilley KS, Ralser M. Dia-nn: neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods. 2020;17(1):41\u20134.","journal-title":"Nat Methods"},{"issue":"1","key":"466_CR28","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"1","key":"466_CR29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/exnr.1996.0043","volume":"138","author":"A Afagh","year":"1996","unstructured":"Afagh A, Cummings BJ, Cribbs DH, Cotman CW, Tenner AJ. Localization and cell association of c1q in Alzheimer\u2019s disease brain. Exp Neurol. 1996;138(1):22\u201332.","journal-title":"Exp Neurol"},{"issue":"36","key":"466_CR30","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O\u2019Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N, Deng S, Liddelow SA, Zhang C, Daneman R, Maniatis T, Barres BA, Wu JQ. An rna-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34(36):11929\u201347.","journal-title":"J Neurosci"},{"issue":"11","key":"466_CR31","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1177\/0271678X221111602","volume":"42","author":"M Suzuki","year":"2022","unstructured":"Suzuki M, Tezuka K, Handa T, Sato R, Takeuchi H, Takao M, Tano M, Uchida Y. Upregulation of ribosome complexes at the blood-brain barrier in Alzheimer\u2019s disease patients. J Cereb Blood Flow Metab. 2022;42(11):2134\u201350.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"466_CR32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","volume":"20","author":"CD Arvanitis","year":"2020","unstructured":"Arvanitis CD, Ferraro GB, Jain RK. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer. 2020;20(1):26\u201341.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"466_CR33","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ymthe.2018.02.032","volume":"26","author":"H Sonoda","year":"2018","unstructured":"Sonoda H, Morimoto H, Yoden E, Koshimura Y, Kinoshita M, Golovina G, Takagi H, Yamamoto R, Minami K, Mizoguchi A, Tachibana K, Hirato T, Takahashi K. A blood-brain-barrier-penetrating anti-human transferrin receptor antibody fusion protein for neuronopathic mucopolysaccharidosis ii. Mol Ther. 2018;26(5):1366\u201374.","journal-title":"Mol Ther"},{"issue":"6","key":"466_CR34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","volume":"12","author":"WM Pardridge","year":"1995","unstructured":"Pardridge WM, Kang YS, Buciak JL, Yang J. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm Res. 1995;12(6):807\u201316.","journal-title":"Pharm Res"},{"issue":"4","key":"466_CR35","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1471-4159.2008.05492.x","volume":"106","author":"M Demeule","year":"2008","unstructured":"Demeule M, Currie JC, Bertrand Y, Che C, Nguyen T, Regina A, Gabathuler R, Castaigne JP, Beliveau R. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem. 2008;106(4):1534\u201344.","journal-title":"J Neurochem"},{"issue":"2","key":"466_CR36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.7150\/thno.17155","volume":"7","author":"G Hultqvist","year":"2017","unstructured":"Hultqvist G, Syvanen S, Fang XT, Lannfelt L, Sehlin D. Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor. Theranostics. 2017;7(2):308\u201318.","journal-title":"Theranostics"},{"issue":"1","key":"466_CR37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41467-017-00952-3","volume":"8","author":"Y Anraku","year":"2017","unstructured":"Anraku Y, Kuwahara H, Fukusato Y, Mizoguchi A, Ishii T, Nitta K, Matsumoto Y, Toh K, Miyata K, Uchida S, Nishina K, Osada K, Itaka K, Nishiyama N, Mizusawa H, Yamasoba T, Yokota T, Kataoka K. Glycaemic control boosts glucosylated nanocarrier crossing the bbb into the brain. Nat Commun. 2017;8(1):1001.","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"466_CR38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0165-5728(01)00242-9","volume":"114","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Pardridge WM. Mediated efflux of igg molecules from brain to blood across the blood-brain barrier. J Neuroimmunol. 2001;114(1\u20132):168\u201372.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"466_CR39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1471-4159.2002.00840.x","volume":"81","author":"F Schlachetzki","year":"2002","unstructured":"Schlachetzki F, Zhu C, Pardridge WM. Expression of the neonatal fc receptor (fcrn) at the blood-brain barrier. J Neurochem. 2002;81(1):203\u20136.","journal-title":"J Neurochem"},{"issue":"12","key":"466_CR40","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV. Clearance of alzheimer\u2019s amyloid-ss(1\u201340) peptide from brain by ldl receptor-related protein-1 at the blood-brain barrier. J Clin Investig. 2000;106(12):1489\u201399.","journal-title":"J Clin Investig"},{"issue":"17","key":"466_CR41","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1523\/JNEUROSCI.5103-08.2009","volume":"29","author":"H Xiong","year":"2009","unstructured":"Xiong H, Callaghan D, Jones A, Bai J, Rasquinha I, Smith C, Pei K, Walker D, Lue LF, Stanimirovic D, Zhang W. Abcg2 is upregulated in Alzheimer\u2019s brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for abeta(1\u201340) peptides. J Neurosci. 2009;29(17):5463\u201375.","journal-title":"J Neurosci"},{"issue":"1","key":"466_CR42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JAD-122077","volume":"38","author":"S Ito","year":"2014","unstructured":"Ito S, Ohtsuki S, Murata S, Katsukura Y, Suzuki H, Funaki M, Tachikawa M, Terasaki T. Involvement of insulin-degrading enzyme in insulin- and atrial natriuretic peptide-sensitive internalization of amyloid-beta peptide in mouse brain capillary endothelial cells. J Alzheimers Dis. 2014;38(1):185\u2013200.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"466_CR43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","volume":"126","author":"SE Storck","year":"2016","unstructured":"Storck SE, Meister S, Nahrath J, Meissner JN, Schubert N, Di Spiezio A, Baches S, Vandenbroucke RE, Bouter Y, Prikulis I, Korth C, Weggen S, Heimann A, Schwaninger M, Bayer TA, Pietrzik CU. Endothelial lrp1 transports amyloid-beta(1\u201342) across the blood-brain barrier. J Clin Investig. 2016;126(1):123\u201336.","journal-title":"J Clin Investig"},{"key":"466_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.07.017","author":"SE Storck","year":"2018","unstructured":"Storck SE, Hartz AMS, Bernard J, Wolf A, Kachlmeier A, Mahringer A, Weggen S, Pahnke J, Pietrzik CU. The concerted amyloid-beta clearance of lrp1 and abcb1\/p-gp across the blood-brain barrier is linked by picalm. Brain Behav Immun. 2018;73:21\u201333.","journal-title":"Brain Behav Immun"},{"issue":"6","key":"466_CR45","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1111\/j.1471-4159.2007.04938.x","volume":"103","author":"S Ito","year":"2007","unstructured":"Ito S, Ohtsuki S, Kamiie J, Nezu Y, Terasaki T. Cerebral clearance of human amyloid-beta peptide (1\u201340) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes. J Neurochem. 2007;103(6):2482\u201390.","journal-title":"J Neurochem"},{"issue":"14","key":"466_CR46","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci USA. 2011;108(14):5819\u201324.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"466_CR47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"466_CR48","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1242\/dev.01037","volume":"131","author":"E P\u00f6schl","year":"2004","unstructured":"P\u00f6schl E, Schl\u00f6tzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U. Collagen iv is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development. 2004;131(7):1619\u201328.","journal-title":"Development"},{"issue":"14","key":"466_CR49","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa053727","volume":"354","author":"DB Gould","year":"2006","unstructured":"Gould DB, Phalan FC, van Mil SE, Sundberg JP, Vahedi K, Massin P, Bousser MG, Heutink P, Miner JH, Tournier-Lasserve E, John SW. Role of col4a1 in small-vessel disease and hemorrhagic stroke. N Engl J Med. 2006;354(14):1489\u201396.","journal-title":"N Engl J Med"},{"issue":"5725","key":"466_CR50","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.1109418","volume":"308","author":"DB Gould","year":"2005","unstructured":"Gould DB, Phalan FC, Breedveld GJ, van Mil SE, Smith RS, Schimenti JC, Aguglia U, van der Knaap MS, Heutink P, John SW. Mutations in col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science. 2005;308(5725):1167\u201371.","journal-title":"Science"},{"issue":"7323","key":"466_CR51","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature09513","volume":"468","author":"R Daneman","year":"2010","unstructured":"Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010;468(7323):562\u20136.","journal-title":"Nature"},{"key":"466_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3932","author":"AP Sagare","year":"2013","unstructured":"Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A, Zlokovic BV. Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun. 2013;4:2932.","journal-title":"Nat Commun"},{"issue":"9","key":"466_CR53","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1469-8749.2007.00707.x","volume":"49","author":"J Klepper","year":"2007","unstructured":"Klepper J, Leiendecker B. Glut1 deficiency syndrome\u20132007 update. Dev Med Child Neurol. 2007;49(9):707\u201316.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"466_CR54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.nbd.2009.10.022","volume":"37","author":"O Braissant","year":"2010","unstructured":"Braissant O, Beard E, Torrent C, Henry H. Dissociation of agat, gamt and slc6a8 in cns: relevance to creatine deficiency syndromes. Neurobiol Dis. 2010;37(2):423\u201333.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"466_CR55","doi-asserted-by":"crossref","first-page":"e12632","DOI":"10.15252\/emmm.202012632","volume":"13","author":"M Bae","year":"2021","unstructured":"Bae M, Roh JD, Kim Y, Kim SS, Han HM, Yang E, Kang H, Lee S, Kim JY, Kang R, Jung H, Yoo T, Kim H, Kim D, Oh H, Han S, Kim D, Han J, Bae YC, Kim H, Ahn S, Chan AM, Lee D, Kim JW, Kim E. Slc6a20 transporter: a novel regulator of brain glycine homeostasis and nmdar function. EMBO Mol Med. 2021;13(2):e12632.","journal-title":"EMBO Mol Med"},{"issue":"24","key":"466_CR56","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1093\/emboj\/20.24.7041","volume":"20","author":"FA Chaudhry","year":"2001","unstructured":"Chaudhry FA, Krizaj D, Larsson P, Reimer RJ, Wreden C, Storm-Mathisen J, Copenhagen D, Kavanaugh M, Edwards RH. Coupled and uncoupled proton movement by amino acid transport system n. Embo J. 2001;20(24):7041\u201351.","journal-title":"Embo J"},{"issue":"2","key":"466_CR57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00424-015-1742-0","volume":"468","author":"K Chan","year":"2016","unstructured":"Chan K, Busque SM, Sailer M, Stoeger C, Br\u00f6er S, Daniel H, Rubio-Aliaga I, Wagner CA. Loss of function mutation of the slc38a3 glutamine transporter reveals its critical role for amino acid metabolism in the liver, brain, and kidney. Pflugers Arch. 2016;468(2):213\u201327.","journal-title":"Pflugers Arch"},{"issue":"4","key":"466_CR58","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.WCB.0000050062.57184.75","volume":"23","author":"S Mori","year":"2003","unstructured":"Mori S, Takanaga H, Ohtsuki S, Deguchi T, Kang YS, Hosoya K, Terasaki T. Rat organic anion transporter 3 (roat3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J Cereb Blood Flow Metab. 2003;23(4):432\u201340.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"466_CR59","first-page":"435","volume":"25","author":"HJ Stuerenburg","year":"2004","unstructured":"Stuerenburg HJ, Ganzer S, M\u00fcller-Thomsen T. 5-hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer\u2019s disease, depression and mild cognitive impairment. Neuro Endocrinol Lett. 2004;25(6):435\u20137.","journal-title":"Neuro Endocrinol Lett"},{"issue":"2","key":"466_CR60","doi-asserted-by":"crossref","first-page":"174","DOI":"10.9758\/cpn.2020.18.2.174","volume":"18","author":"A Ayka","year":"2020","unstructured":"Ayka A, \u015eehirli A. The role of the slc transporters protein in the neurodegenerative disorders. Clin Psychopharmacol Neurosci. 2020;18(2):174\u201387.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"5","key":"466_CR61","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1038\/tp.2015.52","volume":"5","author":"C Madeira","year":"2015","unstructured":"Madeira C, Lourenco MV, Vargas-Lopes C, Suemoto CK, Brand\u00e3o CO, Reis T, Leite RE, Laks J, Jacob-Filho W, Pasqualucci CA, Grinberg LT, Ferreira ST, Panizzutti R. D-serine levels in Alzheimer\u2019s disease: implications for novel biomarker development. Transl Psychiatry. 2015;5(5):e561.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"466_CR62","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00424-003-1146-4","volume":"447","author":"Y Kanai","year":"2004","unstructured":"Kanai Y, Hediger MA. The glutamate\/neutral amino acid transporter family slc1: molecular, physiological and pharmacological aspects. Pflugers Arch. 2004;447(5):469\u201379.","journal-title":"Pflugers Arch"},{"issue":"17","key":"466_CR63","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.cub.2016.07.017","volume":"26","author":"T Niccoli","year":"2016","unstructured":"Niccoli T, Cabecinha M, Tillmann A, Kerr F, Wong CT, Cardenes D, Vincent AJ, Bettedi L, Li L, Gr\u00f6nke S, Dols J, Partridge L. Increased glucose transport into neurons rescues a\u03b2 toxicity in drosophila. Curr Biol. 2016;26(17):2291\u2013300.","journal-title":"Curr Biol"},{"issue":"7","key":"466_CR64","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","volume":"12","author":"S Vogelgesang","year":"2002","unstructured":"Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W, Kunert-Keil C, Walker LC, Warzok RW. Deposition of Alzheimer\u2019s beta-amyloid is inversely correlated with p-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics. 2002;12(7):535\u201341.","journal-title":"Pharmacogenetics"},{"key":"466_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.08.034","author":"HC Wijesuriya","year":"2010","unstructured":"Wijesuriya HC, Bullock JY, Faull RL, Hladky SB, Barrand MA.\u00a0ABC efflux transporters in brain vasculature of Alzheimer\u2019s subjects. Brain Res. 2010;1358:228\u201338.","journal-title":"Brain Res"},{"issue":"1","key":"466_CR66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","volume":"5","author":"GJ Biessels","year":"2006","unstructured":"Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64\u201374.","journal-title":"Lancet Neurol"},{"issue":"1","key":"466_CR67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/mp3004308","volume":"10","author":"S Ohtsuki","year":"2013","unstructured":"Ohtsuki S, Ikeda C, Uchida Y, Sakamoto Y, Miller F, Glacial F, Decleves X, Scherrmann JM, Couraud PO, Kubo Y, Tachikawa M, Terasaki T. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hcmec\/d3 as a human blood-brain barrier model. Mol Pharm. 2013;10(1):289\u201396.","journal-title":"Mol Pharm"},{"issue":"7","key":"466_CR68","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s11095-021-03131-8","volume":"39","author":"H Nagano","year":"2022","unstructured":"Nagano H, Ito S, Masuda T, Ohtsuki S. Effect of insulin receptor-knockdown on the expression levels of blood-brain barrier functional proteins in human brain microvascular endothelial cells. Pharm Res. 2022;39(7):1561\u201374.","journal-title":"Pharm Res"},{"issue":"9","key":"466_CR69","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.xphs.2017.04.036","volume":"106","author":"S Ito","year":"2017","unstructured":"Ito S, Yanai M, Yamaguchi S, Couraud PO, Ohtsuki S. Regulation of tight-junction integrity by insulin in an in vitro model of human blood-brain barrier. J Pharm Sci. 2017;106(9):2599\u2013605.","journal-title":"J Pharm Sci"},{"issue":"1\u20133","key":"466_CR70","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejphar.2007.01.062","volume":"561","author":"H Liu","year":"2007","unstructured":"Liu H, Zhang D, Xu X, Liu X, Wang G, Xie L, Pang X, Liu L. Attenuated function and expression of p-glycoprotein at blood-brain barrier and increased brain distribution of phenobarbital in streptozotocin-induced diabetic mice. Eur J Pharmacol. 2007;561(1\u20133):226\u201332.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"466_CR71","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.brainres.2006.09.061","volume":"1123","author":"H Liu","year":"2006","unstructured":"Liu H, Xu X, Yang Z, Deng Y, Liu X, Xie L. Impaired function and expression of p-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats. Brain Res. 2006;1123(1):245\u201352.","journal-title":"Brain Res"},{"issue":"23\u201326","key":"466_CR72","first-page":"775","volume":"85","author":"KC Wu","year":"2009","unstructured":"Wu KC, Pan HJ, Yin HS, Chen MR, Lu SC, Lin CJ. Change in p-glycoprotein and caveolin protein expression in brain striatum capillaries in New Zealand obese mice with type 2 diabetes. Life Sci. 2009;85(23\u201326):775\u201381.","journal-title":"Life Sci"},{"issue":"8","key":"466_CR73","doi-asserted-by":"crossref","first-page":"100138","DOI":"10.1016\/j.xcrm.2020.100138","volume":"1","author":"P Baloni","year":"2020","unstructured":"Baloni P, Funk CC, Yan J, Yurkovich JT, Kueider-Paisley A, Nho K, Heinken A, Jia W, Mahmoudiandehkordi S, Louie G, Saykin AJ, Arnold M, Kastenm\u00fcller G, Griffiths WJ, Thiele I, Kaddurah-Daouk R, Price ND. Metabolic network analysis reveals altered bile acid synthesis and metabolism in Alzheimer\u2019s disease. Cell Rep Med. 2020;1(8):100138.","journal-title":"Cell Rep Med"},{"issue":"1","key":"466_CR74","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/dmd.109.029454","volume":"38","author":"A Ose","year":"2010","unstructured":"Ose A, Kusuhara H, Endo C, Tohyama K, Miyajima M, Kitamura S, Sugiyama Y. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier. Drug Metab Dispos. 2010;38(1):168\u201376.","journal-title":"Drug Metab Dispos"},{"issue":"26","key":"466_CR75","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","volume":"96","author":"KR Bales","year":"1999","unstructured":"Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, Fishman CE, DeLong CA, Piccardo P, Petegnief V, Ghetti B, Paul SM. Apolipoprotein e is essential for amyloid deposition in the app(v717f) transgenic mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 1999;96(26):15233\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"466_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd7522","author":"M Xiong","year":"2021","unstructured":"Xiong M, Jiang H, Serrano JR, Gonzales ER, Wang C, Gratuze M, Hoyle R, Bien-Ly N, Silverman AP, Sullivan PM, Watts RJ, Ulrich JD, Zipfel GJ, Holtzman DM. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci Trans Med. 2021;13(581):eabd7522.","journal-title":"Sci Trans Med"},{"issue":"11","key":"466_CR77","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/1873-3468.13428","volume":"593","author":"E Hubin","year":"2019","unstructured":"Hubin E, Verghese PB, van Nuland N, Broersen K. Apolipoprotein e associated with reconstituted high-density lipoprotein-like particles is protected from aggregation. FEBS Lett. 2019;593(11):1144\u201353.","journal-title":"FEBS Lett"},{"issue":"5\u20136","key":"466_CR78","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0197-0186(01)00049-3","volume":"39","author":"RB DeMattos","year":"2001","unstructured":"DeMattos RB, Brendza RP, Heuser JE, Kierson M, Cirrito JR, Fryer J, Sullivan PM, Fagan AM, Han X, Holtzman DM. Purification and characterization of astrocyte-secreted apolipoprotein e and j-containing lipoproteins from wild-type and human apoe transgenic mice. Neurochem Int. 2001;39(5\u20136):415\u201325.","journal-title":"Neurochem Int"},{"issue":"39","key":"466_CR79","doi-asserted-by":"crossref","first-page":"41197","DOI":"10.1074\/jbc.M407962200","volume":"279","author":"V Hirsch-Reinshagen","year":"2004","unstructured":"Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, Tansley GH, Cohn JS, Hayden MR, Wellington CL. Deficiency of abca1 impairs apolipoprotein e metabolism in brain. J Biol Chem. 2004;279(39):41197\u2013207.","journal-title":"J Biol Chem"},{"key":"466_CR80","doi-asserted-by":"crossref","unstructured":"Herring SK, Moon HJ, Rawal P, Chhibber A, Zhao L. Brain clusterin protein isoforms and mitochondrial localization. eLife. 2019;8:e48255.","DOI":"10.7554\/eLife.48255"},{"issue":"5","key":"466_CR81","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","volume":"36","author":"L Mosconi","year":"2009","unstructured":"Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, Pirraglia E, De Santi S, Reisberg B, Wisniewski T, de Leon MJ. Fdg-pet changes in brain glucose metabolism from normal cognition to pathologically verified alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2009;36(5):811\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"466_CR82","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","volume":"32","author":"L Mosconi","year":"2005","unstructured":"Mosconi L. Brain glucose metabolism in the early and specific diagnosis of alzheimer\u2019s disease. Fdg-pet studies in mci and ad. Eur J Nucl Med Mol Imaging. 2005;32(4):486\u2013510.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"466_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2016.07.001","author":"A Masuda","year":"2016","unstructured":"Masuda A, Kobayashi Y, Kogo N, Saito T, Saido TC, Itohara S. Cognitive deficits in single app knock-in mouse models. Neurobiol Learn Mem. 2016;135:73-82.","journal-title":"Neurobiol Learn Mem"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-023-00466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-023-00466-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-023-00466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T10:26:47Z","timestamp":1700303207000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-023-00466-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1186\/s12987-023-00466-9","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"4 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of Kumamoto University (no. A2019-031, A2021-041), following the Fundamental Guidelines for Proper Conduct of Animal Experiments and Related Activities in Academic Research Institutions, under the jurisdiction of the Ministry of Education, Culture, Sports, Science, and Technology and Animal Research: Reporting in Vivo Experiments Guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}